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Background: Vulvovaginal candidiasis (VVC) is a common disease which infects women. The current study investigated the performance of direct sample polymerase chain reaction (DS-PCR) method to detect Candida spp. in clinical samples of vulvovaginitisto compare the results to those of standard microbiological laboratory methods.
Objectives: The current study aimed to further simplify the DNA extraction procedure, and shorten the time required for isolation and identification by using direct PCR to identify Candida vulvovaginitis without DNA extraction from samples or colonies.
Patients and Methods: In the current study, totally 150 sexually active women participated. Vaginal discharge samples were collected using two sterile Dacron swabs that were immediately placed in two tubes each containing 1 mL of distilled water. One of the tubes was used for conventional culture methods whereas the other one was used for DS-PCR without DNA extraction. The number of yeast cells in each sample was counted.
Results: The results showed that out of the 150 samples, 55 were positive and 63 samples were negative by both methods, and 32 samples were positive using the culture method, but negative by DS-PCR. All positive DS-PCR samples had > 107 yeast or conidia cells/mL. The sensitivity and specificity of DS-PCR were calculated as 63.2% and 100%, respectively.
Conclusions: Direct sample PCR has the potential to rapidly and accurately diagnose Candida vulvovaginitis in patients, especially if sufficient samples are obtained.
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1. BackgroundVulvovaginal candidiasis (VVC) is a common disease which infects women and may affect their physical and emotional health, as well as relationships with their sex-ual partners. Conventional methods to identify Candida species are based on culture, assimilation, fermentation reactions, and morphology. However, these techniques are time-consuming and their reliance on phenotypic expres-sion makes them potentially unreliable. To overcome the many limitations of phenotypic methods involve diagno-sis of vulvovaginal candidiasis, recent advances in molecu-lar DNA analysis have facilitated the development of iden-tification systems at the species level (1). DNA isolation and purification is a key step for most protocols in molecular biological studies, including polymerase chain reaction (PCR). Various methods proposed that extraction and pu-rification of yeast DNA can be classified according to the following cells lysis techniques: bead beating, enzymatic cell wall lyses using lyticase, or cell permeabilization using chaotropic agents. However, these techniques are general-ly very time-consuming. Moreover, some protocols require additional lyses steps, such as mechanical disruption and 
sonification, or the use of toxic substances such as phenol-chloroform solution (2). In essence, these approaches are no faster than conventional approaches because first, the organism must be isolated in pure culture (3).In contrast, a number of reports have described the PCR amplification of purified DNA extracted from clinical 
Candida specimens (2); however, the drawback to these approaches is the additional time for genomic DNA ex-traction required for the amplification of specific genes.
2. ObjectivesThe current study aimed to further simplify the DNA ex-traction procedure and shorten the time required for iso-lation in culture and identification by using direct PCR to identify Candida vulvovaginitis without DNA extraction.
3. Patients and Methods
3.1. Clinical SamplesOne hundred and fifty cases examined for inclusion 
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criteria of vulvovaginal candidiasis (age 15 to 50, non-pregnant, without drug use, with severe itching and ab-normal vaginal discharge). In their routine clinical labo-ratory diagnosis, all vaginal specimens were collected in the health and medical clinics and hospitals of Qazvin University of Medical Sciences (Qazvin, Iran) from March to December 2012. Vaginal discharge samples were col-lected with sterile Dacron swabs and then deposited into two tubes, each containing 1mL of sterile distilled water. Yeast cells were counted in each sample (using a hemo-cytometer); one of the tubes was used for standard con-ventional phenotypic and mycological methods and the other for direct sample PCR (DS-PCR), in which aliquots of the samples were directly used as templates that opposed to the conventional templates of purified extracted ge-nomic DNA for routine PCR.
3.1.1.Phenotypic and Mycological EvaluationsPhenotypic and mycological evaluations were per-formed by direct slide preparations as well as germ tube, chlamydospore formation, and specially culture in chrome agar to detect color of the colonies (4-6).
3.1.2. Sensitivity Detection Limit and Determination of 
Minimum Yeast Concentration for Performing DS-PCRSerial dilutions (1010–1) of C. albicans cells (ATCC 10231) were prepared (enumerated microscopically using a he-mocytometer). Five microliters of each suspension was used as DS-PCR template.
3.2. PrimersThe following universal (pan fungal) primers were syn-thesized by metabion international AG. (Planegg-Martin-sried, Germany):a) ITS1 or F (5’-TCC GTA GGT GAA CCT GCG G-3’);b) ITS4 or R (5’-TCCTCC GCT TAT TGA TAT GC-3’) (1, 2, 7-9).
3.3. Polymerase Chain ReactionFor the present comparative study, DS-PCR was per-formed for each of the 150 clinical samples. Optimal PCR 
conditions were as follows: a reaction volume of 25 μL 
contained 10 μL of master mix (Amplicon, Denmark), 1 
μL of each F and R primers, 5 μL of the sample as a di-
rect template, and remaining volume (8 μL) of distilled water (DW). A negative control containing sterile de-ionized water and a positive control of C. albicans DNA (ATCC 10231) were included in each PCR run. Reaction mixtures were subjected to an initial denaturation step at 94°C for seven minutes followed by 30 cycles of de-naturation at 94°C for 45 seconds, annealing at 56°C for one minute, and extension at 72°C for one minute, with a final extension at 72°C for seven minutes (1, 2, 8) in Veriti Thermal Cycler ABI (applied biosystems, Foster City, CA, USA).
3.4. Electrophoresis AnalysisThe PCR products were subjected to 2% agaros gel elec-trophoresis and the gels were stained with gel red (power load). A 100-basepair DNA ladder (Intron Biotechnology Inc.) was used for all experiments.
3.5. Statistical MethodsThe data were analyzed using SPSS software, version 16 (SPSS Inc., Chicago, IL). Cross tabulations, and 2×2 contin-gency tables were used to calculate sensitivity and speci-ficity with a 95% confidence interval. The test sensitivity of the DS-PCR was defined as the number of strains correctly identified in the conventional culture as the gold stan-dard method (true positives) divided by the total number of isolated yeast strains. The test specificity was defined as the number of strains which were not identified by DS-PCR (true negatives) divided by the total number of strains.
4. ResultsThe mean age of the participants was 32 ± 10.5 years (range, 21.5–42.5 years).
4.1. Detection of the sensitivity of Direct Sample 
Polymerase Chain Reaction or analytical sensitiv-
ity Electrophoresis of the direct PCR products of serially di-luted yeast cells of 107 cells/mLor more, revealed a visible band (in between of 510 to 870 bp (Figure 1), suggesting that the simulated patient samples containing the above-mentioned number of yeasts are detectable; therefore, actual samples with these yeast concentrations should be detectable through this method.
Figure 1. Agarose Gel Electrophoresis of DS-PCR of Serially Diluted Yeast Cells
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4.2. Comparison between suggested Polymerase 
Chain Reaction and Mycological Methods to De-
tect Candida vulvovaginitisOf the 150 samples, 55 were positive by both methods (DS-PCR and mycological methods), 32 were positive by mycological evaluations, but negative by DS-PCR and 63 cases were negative by both methods. In total, from 87 
Candida species identified through mycological meth-ods, 73 C. albicans, 12 C. glabrata and two C. tropicalis were identified.The constructed tables of TP (true positive), TN (true neg-ative), FP (false positive), and FN (false negative) results, from which test sensitivity, test specificity, PPV and NPV with 95% confidence intervals were calculated as follow:
4.2.1. SensitivityAbility of DS-PCR to diagnose the vulvovaginitis was 63.2%, which is relatively acceptable.
4.2.2. SpecificityThe Ability of DS-PCR to exclude vulvovaginitis was ex-cellent. It means that the accuracy of DS-PCR to correctly diagnose vulvovaginitis was 100%.
4.2.3. PPV (Positive Predictive Value)Extent to which a positive DS-PCR indicates vulvovagini-tisin a given population was excellent (100%).
4.2.4. NPV (Negative Predictive Value)Extent to which a negative DSPCR exclude the vulvo-vaginitis in a given population was fair (66.3%) (Table 1).All DS-PCR-positive samples had more than 107 yeast cells per mL (55 cases), but 32 positive culture and nega-tive DS-PCR samples contained less than 107 yeast cells per mL, and did not reveal visible electrophoretic bands (Figure 2).
Table 1. Performance Characteristics of DS-PCR Test for Detec-tion of Candida to Detect Vulvovaginitis (n = 150) a,b,c
DS DS-PCR (New 
Test)
Culture Mycological Methods (Gold 
Method)
Negative (n = 63) Positive (n = 87)
Positive (n = 87) FP = 0 TP = 55
Negative (n = 63) TN = 63 FN = 32
a Abbreviations: DS-PCR, direct sample polymerase chain reaction; FP, false-positive; FN, false-negative; TN, true-negative; TP, true-positive.b Test sensitivity: TP/ (TP+FN) × 100 = 55/ (55+32) × 100 = 63.2%; Test specificity: TN/ (TN+FP) × 100 = 63/ (63+0) × 100 = 100%; PPV: 55/ (55+0) × 100 = 100%.c NPV: 63/ (63+32) × 100 = 66.3%.
Figure 2. Agarose Gel Electrophoresis to compare two methods for detec-tion of Candida Vulvovaginitis
(Lanes 1, positive control of C. albicans; 2, negative control of DW; 3 and 4, negative DS-PCR and mycological diagnosed samples, respectively; 5 and 7, positive mycological sample and the same sample for DS-PCR, re-spectively; 6, another positive control of C. glabrata; 8, a positive DS-PCR sample, and 9a 100 bp size marker).
5. DiscussionIt is generally accepted that DNA extraction from yeasts, either by enzymatic lysis or by bead sonication followed by phenol-chloroform extraction, is the most tedious and cumbersome step of a PCR-based identification method (10) and additional time to culture the clinical specimens and colony isolation, limits its routine use in the clinical laboratories (2). This is the first study which describes a rapid and reliable detection and identification method for clinically relevant Candida species directly from vul-vovaginitis samples, which can aid clinicians to the faster and more reliable method, without need for growing the microorganisms or performing additional laboratory procedures, such as DNA extraction.Previous studies regarding the evaluation of DC-PCR (i.e. DC-PCR) to detect Candida species concluded that it is feasible to start PCR directly from Candida colonies without DNA of colonies to be extracted (2, 11). Further-more, other studies to the detection of Candida species and fungemia directly from blood cultures vials by PCR methods, reported that it is possible to detect DNA of or-ganisms in the patients` blood samples without the need for culture and colony formation (10, 12, 13).By combining these findings, the current study exam-ined the applicability of DS-PCR to detect Candida spe-cies in vulvovaginitis, using direct samples on clinical swabs (colonization of Candida species in such situations results in true in-vivo colonies rather than presence of single cell Candida in normal flora samples).Undoubtedly, fungal cell breakage and subsequent release of genomic DNA in these conditions are less effi-cient than the preliminary true extraction of DNA. How-ever, in ideal vulvovaginal sampling, adequate DNA tem-plates are available to yield positive PCR tests (2).Also, intact yeast cells are steadily amplified, probably 
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because in perfect vulvovaginal sampling, numerous cells are collected and the amplified rDNA are present in multiple copies (> 100) per genome (14). Therefore, it seems possible that during the various thermal PCR cycles the release of DNA from yeast cells will yield suf-ficient templates (intact DNA) to promote PCR amplifi-cation of the abundant rDNA in the yeast genome. This is why some DNA extraction protocols and kits employ only the boiling and thermal steps for an efficient lysis step (10). The use of FTA-card system (Whatman Inc., Pis-cataway, NJ, USA) to instantly lyse yeast cells after heat-ing can produce sufficient yeast DNA templates for PCR. Chang et al. (10) reported that the only step used for DNA extraction with their recommended kit (microlysis) was heating of yeast cell suspensions in the lysis solution in a thermal cycler ; thereby, eliminating the use of phenol-chloroform and alcohol for DNA purification and precipi-tation, respectively.It is obvious that among the most important factors that limit the application of DS-PCR to amplify Candida DNA in vaginal samples is the concentration of yeast cells in the samples which must be more than 107/mL. Therefore, to achieve precise results, a high yeast content sample and experienced technologists are required; otherwise, false-negative (FN) results and low sensitivity of the test may occur. Therefore, to reduce FN results and improve test sensitivity as well as NPV, counting of yeast cells in the samples and having concentrations above 107/mL is mandatory. In fact, Mirhendi et al. (2) reported that at least 106 Candida cells are needed to perform their recom-mended DC-PCR (direct colony PCR). There were no false positive (FP) results in our suggested DS-PCR method which meant that every positive result of this technique indicated vulvovaginitis in patients.Another important limiting factor of DS-PCR, as well as conventional PCR, to detect Candida species in vaginal samples is the use of universal primers to amplify the highly conserved 5.8 S region of rDNA and its adjacent ITS1 and ITS4sequences in Candida species (15), which may have similarities with other eukaryotic rDNAs, including those from humans and other fungi. For example, other yeasts such as Geothrichum and especially Trichosporon species are sometimes isolated from vaginal infection (16, 17) and PCR amplification by ITS1 and ITS4 primers for these fungi may yield amplicon sizes in the ranges of Can-
dida species (9). Although size determination of the PCR products gives a possible species, subsequent restriction analysis and PCR melting profile (PCR MP) as well as ITS region nucleotide sequencing lead to accurate diagnosis of the relevant yeasts at the species levels (1, 14, 18, 19).Although there were no such yeasts in the cultures of the samples of the current study, it is recommended that in the future, to perform DS-PCR, such similarities should be evaluated. If these sequences match human or other fun-gi DNA-derived sequences, new Candida-specific primers (20) must be designed to permit sole detection of the ma-jor clinically important species present in the specimens.
In conclusion the DS-PCR method has the potential to rapidly and accurately diagnose Candida vulvovaginitis and the samples obtained directly from patients may be preferred to mycological laboratory methods and/or DNA extracted samples, since they can provide an op-portunity for a rapid and direct PCR. In future, the cur-rent study authors plan to study the application of this method for other pathogenic fungi, including medically important moulds present in other clinical specimens. However, to release DNA from such fungi samples and obtain good results, a prior digestion step using lyticase enzyme is recommended.
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